Showing results (271-280 of 297) with videos related to

Sort By:
Pageof 30
Bulletin Du Cancer|January 1, 1990
[Conservative treatment of breast cancer (the Lyon experience during 1963-1983)]X Montbarbon, J M Ardiet, J L Chassard, et al.
Cancer Treatment Reports|March 1, 1986
Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in miceN J Patronas, J S Cohen, R H Knop, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2018
[Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases]I Barillot, D Antoni, J Bellec, et al.
Revue Des Maladies Respiratoires|December 25, 2008
[Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency]G Thabut, J-F Mornex, A Cuvelier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 20, 2000
[Evaluating radiotherapy patients' need for information: a study using a patient information booklet]V Bonnet, C Couvreur, P Demachy, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 5, 2015
[Adaptive radiation therapy for non-small cell lung cancer]J-E Bibault, A Arsène-Henry, C Durdux, et al.
British Journal of Cancer|July 27, 2006
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II studyA W Blackstock, F Mornex, C Partensky, et al.
Revue De Pneumologie Clinique|July 26, 2015
[Graft-versus-host disease, a rare complication of lung transplantation]H Morisse-Pradier, R Nove-Josserand, F Philit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO studyB Chauffert, F Mornex, F Bonnetain, et al.
Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.
Pageof 30